Learn More

November 30, 2023 | Volume XIV | Issue 48

U.S. life expectancy starts to recover

NPR reports via Health News Florida:

The average life expectancy in the U.S. is now 77.5 years old, according to provisional 2022 data published by the Centers for Disease Control and Prevention.

That represents an increase of 1.1 years over 2021 numbers. "The good news is that life expectancy increased for the first time in two years," says Elizabeth Arias, a demographer in the CDC's Division of Vital Statistics and co-author on the paper. "The not-so-good news is that the increase in life expectancy only accounted for less than 50% of the loss that was experienced between 2019 and 2021."

Read More

Learn More

State Farm loses FDUPTA claims against providers

Carlos Arce, Esq.

The jury spoke November 8, 2023 in the pending litigation “State Farm Auto. Ins. Co. v. Michael Thomas Larocca, DC, et al,” case number 8:21-cv-2536-SCB-AEP. The 16 Defendants, which included chiropractors, medical doctors, and nurse practitioners were held not guilty of committing fraud, civil conspiracy, unjust enrichment, and violating the Florida Deceptive and Unfair Trade Practices Act (FDUTPA). State Farm had filed a claim against the 16 defendants back in 2021. The allegations were the usual elements raised by Special Investigation Units (SIU): non-medically necessary procedures and engaging in illegal patient brokering and kickback schemes based on the marketing activities performed by the chiropractic clinic.

For years the SIU has brought forth these sorts of allegations and audits against chiropractors and providers engaged in the personal injury space. November 8 was a big win for those providers. With the passing of HB837, it has been difficult to understand the future of the personal injury protection space and the bodily injury space. Providers are fighting back and are challenging draconian measures passed down by the motor vehicle insurers.

Read More

Users of diabetes drug Mounjaro lost more weight than those on Ozempic, large study finds

Brenda Goodman reports for CNN:

Overweight and obese adults who took the injected medication Mounjaro lost more weight and were more likely to meet specific weight loss targets than people on a similar competitor, Ozempic, according to a new study of people taking the drugs in the real world.

Read More

The lifestyle factors that impact lung cancer risk

KING 5 Seattle

Dr. Daniel Cuadrado and Dr. TJ Templin stress the importance of lung cancer screenings for those at risk. Sponsored by Virginia Mason Franciscan Health.

Watch the video HERE.




Compliance Update

Best Practices

Healthcare Headlines

Game Changers

Last Word

Publisher of Week in Review, Specialty Focus, FHIweekly & Game Changers